Drugs List

Therapeutic Indications

Uses

Inflammatory skin conditions unresponsive to less potent corticosteroids
Plaque psoriasis

Contraindications

Burns
Children under 18 years
Acne vulgaris
Exudative dermatosis
Frostbite
Perioral dermatitis
Rosacea
Skin infection
Skin manifestation of tuberculosis
Skin ulcer

Precautions and Warnings

Breastfeeding
Pregnancy

Careful supervision of patients with psoriasis required
Contains hydroxybenzoate
Avoid occlusive dressings
Cleanse and dry skin before application
Do not apply on or near breasts
Not to be applied to the face
Prolonged use may cause atrophic skin changes
Prolonged/excessive use may lead to adrenal suppression
Risk of generalised pustular psoriasis with use of topical corticosteroids
Withdraw gradually after long-term use
Withdraw gradually if adrenal suppression suspected
Discontinue if hypersensitivity reactions occur

Pregnancy and Lactation

Pregnancy

Use betamethasone valerate medicated plaster with caution during pregnancy.

The manufacturer notes that this medication should only be considered if the expected benefit to the mother is greater than any risk to the foetus, also taking into account the evaluation of the treatment period and the size of the skin area to be treated.

Topical steroids must not be used on large areas of skin or for long periods of time during pregnancy. Topical administration of corticosteroids in pregnant laboratory animals may result in the impairment of foetal development.

Lactation

Use betamethasone valerate medicated plaster with caution during breastfeeding.

The manufacturer notes that this medication should only be considered if the expected benefit to the mother is greater than any risk to the breastfed infant.

Although it is not known if topical corticosteroids are excreted in human milk, systemic corticosteroids are excreted.

Side Effects

Cushing's syndrome
Erosion
Erythema
Formation of pustules
Furuncle
Papules
Pruritus
Skin atrophy
Suppression of the hypothalamic-pituitary-adrenal axis
Telangiectasia

Presentation

Medicated plaster formulation of betamethasone valerate.

Drugs List

Therapeutic Indications

Uses

Inflammatory skin conditions unresponsive to less potent corticosteroids
Plaque psoriasis

Dosage

Adults

Contraindications

Burns
Children under 18 years
Acne vulgaris
Exudative dermatosis
Frostbite
Perioral dermatitis
Rosacea
Skin infection
Skin manifestation of tuberculosis
Skin ulcer

Precautions and Warnings

Breastfeeding
Pregnancy

Careful supervision of patients with psoriasis required
Contains hydroxybenzoate
Avoid occlusive dressings
Cleanse and dry skin before application
Do not apply on or near breasts
Not to be applied to the face
Prolonged use may cause atrophic skin changes
Prolonged/excessive use may lead to adrenal suppression
Risk of generalised pustular psoriasis with use of topical corticosteroids
Withdraw gradually after long-term use
Withdraw gradually if adrenal suppression suspected
Discontinue if hypersensitivity reactions occur

Pregnancy and Lactation

Pregnancy

Use betamethasone valerate medicated plaster with caution during pregnancy.

The manufacturer notes that this medication should only be considered if the expected benefit to the mother is greater than any risk to the foetus, also taking into account the evaluation of the treatment period and the size of the skin area to be treated.

Topical steroids must not be used on large areas of skin or for long periods of time during pregnancy. Topical administration of corticosteroids in pregnant laboratory animals may result in the impairment of foetal development.

Lactation

Use betamethasone valerate medicated plaster with caution during breastfeeding.

The manufacturer notes that this medication should only be considered if the expected benefit to the mother is greater than any risk to the breastfed infant.

Although it is not known if topical corticosteroids are excreted in human milk, systemic corticosteroids are excreted.

Counselling

After application of plaster, do not allow skin to come in contact with water.

If edges of plaster start to lift, apply adhesive strips to secure.

Side Effects

Cushing's syndrome
Erosion
Erythema
Formation of pustules
Furuncle
Papules
Pruritus
Skin atrophy
Suppression of the hypothalamic-pituitary-adrenal axis
Telangiectasia

Overdosage

It is strongly recommended that the UK National Poisons Information Service be consulted on cases of suspected or actual overdose where there is doubt over the degree of risk or about appropriate management.

The following number will direct the caller to the relevant local centre (0844) 892 0111

Information may be obtained if you have access to ToxBase the primary clinical toxicology database of the National Poisons Information Service. This is available via password on the internet ( www.toxbase.org ) or if this is unavailable at the backup site ( www.toxbasebackup.org ).

Further Information

Last Full Review Date: January 2019